HIPEC, or Hyperthermic Intraperitoneal Chemotherapy, is a specialised cancer treatment used during surgery for selected patients whose cancer has spread to the lining of the abdominal cavity, known as the peritoneum.
Dr. Nitin Singhal provides surgical oncology care for complex abdominal and peritoneal cancers, with treatment planning based on the patient's cancer type, disease extent, overall health and suitability for cytoreductive surgery and HIPEC.
Discuss HIPEC Treatment
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a specialised form of cancer treatment in which heated chemotherapy is delivered directly into the abdominal cavity during surgery.
HIPEC is generally considered for selected cancers that have spread to the peritoneal lining. The treatment is usually performed as part of a larger surgical procedure in which visible tumour deposits are removed before the heated chemotherapy is circulated inside the abdomen.
Because the chemotherapy is delivered directly to the abdominal cavity, HIPEC is different from conventional systemic chemotherapy, which circulates throughout the body.
HIPEC is commonly performed together with cytoreductive surgery (CRS) in appropriately selected patients. The aim is to remove visible tumour deposits surgically and then treat the abdominal cavity with heated chemotherapy.
HIPEC treatment involves two major components: cytoreductive surgery and the administration of heated chemotherapy into the abdominal cavity.
The surgeon removes visible tumour deposits from the abdominal cavity as completely as clinically possible.
After tumour removal, a heated chemotherapy solution is circulated directly inside the abdominal cavity.
The chemotherapy is delivered directly to the peritoneal surfaces where microscopic residual cancer cells may remain.
HIPEC is not appropriate for every cancer patient. It is considered for selected patients after detailed evaluation of the cancer type, extent of peritoneal disease, possibility of complete cytoreduction and overall fitness for major surgery.
HIPEC may be considered when cancer has spread to the peritoneum, the lining of the abdominal cavity, in selected clinical situations.
HIPEC is an established treatment approach used in selected appendiceal cancers with peritoneal surface involvement, particularly when cytoreductive surgery is feasible.
Selected patients with colorectal cancer and peritoneal metastases may be evaluated for cytoreductive surgery and HIPEC.
HIPEC may be considered in selected ovarian cancer treatment settings. Patient selection and the timing of HIPEC depend on the specific clinical situation.
In selected advanced gastric cancer cases with peritoneal involvement, cytoreductive surgery and HIPEC may be considered at specialised centres.
Pseudomyxoma peritonei and selected appendiceal mucinous tumours involving the peritoneal cavity may be managed with cytoreductive surgery and HIPEC in appropriate patients.
The suitability of HIPEC depends on individual patient assessment. The following conditions may be considered for HIPEC in appropriate clinical situations.
Advanced appendiceal cancers with peritoneal involvement may be treated using cytoreductive surgery followed by HIPEC in appropriately selected patients.
Selected colorectal cancers that have spread to the peritoneum may be evaluated for cytoreductive surgery and HIPEC depending on disease distribution and the possibility of complete tumour removal.
Selected gastric cancers with peritoneal surface involvement may be considered for HIPEC after detailed assessment of disease extent and surgical suitability.
HIPEC has a role in selected ovarian cancer treatment settings. The decision depends on the disease stage, treatment response and overall clinical circumstances.
This rare condition, often associated with appendiceal mucinous tumours, can involve extensive disease within the abdominal cavity and may be managed with specialised cytoreductive surgery and HIPEC.
HIPEC is primarily a treatment strategy for selected malignancies involving the peritoneal surface. Detailed assessment is required before deciding whether HIPEC is appropriate.
The potential advantages of HIPEC are related to delivering chemotherapy directly to the abdominal cavity after surgical removal of visible tumour deposits. Heat may enhance the effect of some chemotherapy agents, although the benefits depend on the cancer type, treatment setting and individual patient factors.
HIPEC uses heated chemotherapy directly within the abdominal cavity. Hyperthermia may increase the effect of certain chemotherapy agents against cancer cells in the treatment area.
HIPEC delivers chemotherapy directly to the abdominal cavity after cytoreductive surgery, allowing treatment of the peritoneal surfaces where microscopic residual disease may remain.
Patients looking for HIPEC treatment in Ahmedabad may require specialised evaluation because cytoreductive surgery and HIPEC are complex procedures that require careful patient selection, surgical planning and coordinated perioperative care.
Dr. Nitin Singhal specialises in surgical oncology and evaluates patients with complex abdominal and peritoneal cancers to determine whether cytoreductive surgery, HIPEC or another treatment approach is appropriate.
Patients may seek consultation from different parts of Gujarat and across India. International patients may also travel for specialised cancer surgery, depending on their individual diagnosis and treatment requirements.
Dr. Nitin Singhal is a surgical oncologist with more than 15 years of experience in cancer surgery and advanced surgical oncology.
He received surgical oncology training from the world-renowned Tata Memorial Hospital, Mumbai.
His surgical practice includes complex gastrointestinal, colorectal and other abdominal cancers requiring specialised surgical planning.
The choice between surgery, HIPEC, systemic treatment or another approach is based on the individual patient's disease and clinical condition.
Treatment planning focuses on established oncological principles, available clinical evidence and the patient's individual circumstances.
Discuss your diagnosis and understand whether cytoreductive surgery and HIPEC may be appropriate for your condition.
Dr. Nitin Singhal has been recognised for his contribution to cancer care and surgical oncology, reflecting his commitment to advanced surgical techniques, clinical excellence and patient-centred care.
Surgical oncology training from Tata Memorial Hospital, Mumbai.
Expertise across complex and multidisciplinary cancer surgery.
Honoured for excellence in healthcare and surgical oncology.
Focus on evidence-based and personalised cancer treatment.
Recognition that reflects a continued commitment to excellence in cancer care.
